Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Market research
The collection and analysis of data concerning a company's products, customers and markets places. Primary and secondary research tools are used to understand these elements and help a company make successful decisions. Research conducted with a target audience in response to a specific, one-time-only market need is known as ad-hoc market research.
Market Research is recognised as a valuable tool to get the advantage over competitors. Market research provides important information needed to identify and study the market need, market opportunity and competition.
See also:
Marketing strategy
Market Attractiveness
Market Development
Market Entry
Related terms
Market leader, Dichotomous question, Grey market, Market development, Respondent fatigue, Day-after recall, Demand bias, External analysis, Bias, Unstructured question, Trend analysis, Motivation research, International marketing, Construct, Brand revitalisation,
COVID-19 Updates and Daily News
Featured jobs
-
Head of Copy
-
£ competitive
- Pfizer CEO announces plans to launch Omicron-specific COVID-19 vaccine
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- Biogen’s Alzheimer’s treatment Aduhelm limited to clinical trial participants in the US
- Pfizer expands access to lipid nanoparticle technology in new agreement with Acuitas Therapeutics
- BioNTech and InstaDeep collaboration develops SARS-CoV-2 Early Warning System
- BMS and 2seventy bio move away from CAR-T programme
- Live Webinar: Measuring Vital Health Indicators Through Your Camera
- AstraZeneca's Enhertu receives FDA grant for priority review
- Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
- Julie Beeso joins Envision Pharma Group in new Global Director, Professional Development and Engagement role
- Live Webinar: Expanding Access to High-Quality Healthcare
- Vir Biotech launches new research programme for HIV and malaria prevention
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- NAVIGATING 2022: THE FIVE CRITICAL SHIFTS PHARMA NEEDS TO EMBRACE
- Cardiovascular disease: The scale of the challenge
- BMS and Century Therapeutics agree on deal potentially worth over $3bn
- Could femtech be the answer to the gender health gap?
- Cardiovascular disease: The scale of the challenge
